BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 29248579)

  • 1. Genetic profile of patients with early onset inflammatory bowel disease.
    Girardelli M; Basaldella F; Paolera SD; Vuch J; Tommasini A; Martelossi S; Crovella S; Bianco AM
    Gene; 2018 Mar; 645():18-29. PubMed ID: 29248579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
    Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
    Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Cucchiara S; Riegler G; Staiano AM; Ardizzone S; Accomando S; de Angelis GL; Corritore G; Bossa F; Annese V
    World J Gastroenterol; 2008 Aug; 14(29):4643-51. PubMed ID: 18698678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2, IL23R and ATG16L1 polymorphisms in Lithuanian patients with inflammatory bowel disease.
    Sventoraityte J; Zvirbliene A; Franke A; Kwiatkowski R; Kiudelis G; Kupcinskas L; Schreiber S
    World J Gastroenterol; 2010 Jan; 16(3):359-64. PubMed ID: 20082483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between NOD2, IRGM and ORMDL3 polymorphisms and pediatric-onset inflammatory bowel disease in the Lithuanian population.
    Pranculienė G; Steponaitienė R; Skiecevičienė J; Kučinskienė R; Kiudelis G; Adamonis K; Labanauskas L; Kupčinskas L
    Medicina (Kaunas); 2016; 52(6):325-330. PubMed ID: 27932194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation exome sequencing of paediatric inflammatory bowel disease patients identifies rare and novel variants in candidate genes.
    Christodoulou K; Wiskin AE; Gibson J; Tapper W; Willis C; Afzal NA; Upstill-Goddard R; Holloway JW; Simpson MA; Beattie RM; Collins A; Ennis S
    Gut; 2013 Jul; 62(7):977-84. PubMed ID: 22543157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
    Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
    J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping.
    Cutler DJ; Zwick ME; Okou DT; Prahalad S; Walters T; Guthery SL; Dubinsky M; Baldassano R; Crandall WV; Rosh J; Markowitz J; Stephens M; Kellermayer R; Pfefferkorn M; Heyman MB; LeLeiko N; Mack D; Moulton D; Kappelman MD; Kumar A; Prince J; Bose P; Mondal K; Ramachandran D; Bohnsack JF; Griffiths AM; Haberman Y; Essers J; Thompson SD; Aronow B; Keljo DJ; Hyams JS; Denson LA; ; Kugathasan S
    PLoS One; 2015; 10(6):e0128074. PubMed ID: 26098103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing analysis reveals variants in primary immunodeficiency genes in patients with very early onset inflammatory bowel disease.
    Kelsen JR; Dawany N; Moran CJ; Petersen BS; Sarmady M; Sasson A; Pauly-Hubbard H; Martinez A; Maurer K; Soong J; Rappaport E; Franke A; Keller A; Winter HS; Mamula P; Piccoli D; Artis D; Sonnenberg GF; Daly M; Sullivan KE; Baldassano RN; Devoto M
    Gastroenterology; 2015 Nov; 149(6):1415-24. PubMed ID: 26193622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease.
    Xiao Y; Wang XQ; Yu Y; Guo Y; Xu X; Gong L; Zhou T; Li XQ; Xu CD
    World J Gastroenterol; 2016 Jun; 22(24):5578-88. PubMed ID: 27350736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic characterization of inflammatory bowel disease in children under six years of age in China.
    Fang YH; Luo YY; Yu JD; Lou JG; Chen J
    World J Gastroenterol; 2018 Mar; 24(9):1035-1045. PubMed ID: 29531467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms present in IL10, IL23R, NOD2, and ATG16L1 associated with susceptibility to inflammatory bowel disease in Mexican population.
    Quiroz-Cruz S; Posada-Reyes B; Alatorre-García T; Del Real-Calzada CM; García-Samper X; Escobar-Gutiérrez A; Vázquez-Chacón CA; Martínez-Guarneros JA; Cruz-Rivera M; Vaughan G; Fonseca-Coronado S
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):10-16. PubMed ID: 31651650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease.
    Nuij VJAA; Peppelenbosch MP; van der Woude CJ; Fuhler GM
    J Transl Med; 2017 Dec; 15(1):248. PubMed ID: 29228965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
    Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
    Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients.
    Csöngei V; Járomi L; Sáfrány E; Sipeky C; Magyari L; Faragó B; Bene J; Polgár N; Lakner L; Sarlós P; Varga M; Melegh B
    World J Gastroenterol; 2010 Jan; 16(2):176-83. PubMed ID: 20066736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of interleukin 10 receptor gene mutations in children with very early-onset inflammatory bowel disease.
    Beser OF; Conde CD; Serwas NK; Cokugras FC; Kutlu T; Boztug K; Erkan T
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):332-8. PubMed ID: 25373860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic background of inflammatory bowel disease: from correlation to causality.
    Uniken Venema WT; Voskuil MD; Dijkstra G; Weersma RK; Festen EA
    J Pathol; 2017 Jan; 241(2):146-158. PubMed ID: 27785786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
    Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
    Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Sequencing of Pediatric Patients Identifies Mutations in Monogenic Inflammatory Bowel Disease Genes that Translate to Distinct Clinical Phenotypes.
    Ashton JJ; Mossotto E; Stafford IS; Haggarty R; Coelho TAF; Batra A; Afzal NA; Mort M; Bunyan D; Beattie RM; Ennis S
    Clin Transl Gastroenterol; 2020 Feb; 11(2):e00129. PubMed ID: 32463623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.